Literature DB >> 28857485

Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes.

Chi Ma1, Qianfei Zhang1, Tim F Greten1.   

Abstract

Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer-related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these 'intrinsic' effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD-mediated hepatocarcinogenesis. This review explores recent findings of both 'intrinsic' effects on hepatocytes and the role of the local environment in NAFLD-promoted HCC development. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  zzm321990HCCzzm321990; zzm321990NAFLDzzm321990; CD4 T cells; CD8 T cells; ER stress; NKT cells; circadian dysregulation; gut microbiome; inflammatory cytokine; myeloid cells

Mesh:

Year:  2017        PMID: 28857485     DOI: 10.1111/febs.14209

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  20 in total

Review 1.  Systems Challenges of Hepatic Carcinomas: A Review.

Authors:  Dhatri Madduru; Johny Ijaq; Sujata Dhar; Saumyadip Sarkar; Naresh Poondla; Partha S Das; Silvia Vasquez; Prashanth Suravajhala
Journal:  J Clin Exp Hepatol       Date:  2018-05-17

Review 2.  Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer.

Authors:  Kara Wegermann; Jeongeun Hyun; Anna Mae Diehl
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 3.  The functional role of exosome in hepatocellular carcinoma.

Authors:  Hongyu Liu; Baoguo Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

Review 4.  Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.

Authors:  Ahmed Lawan; Anton M Bennett
Journal:  Trends Endocrinol Metab       Date:  2017-11-08       Impact factor: 12.015

5.  The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu.

Authors:  Hans Dieter Nischalke; Philipp Lutz; Eva Bartok; Benjamin Krämer; Bettina Langhans; Regina Frizler; Thomas Berg; Jochen Hampe; Stephan Buch; Christian Datz; Felix Stickel; Gunther Hartmann; Christian P Strassburg; Jacob Nattermann; Ulrich Spengler
Journal:  J Mol Med (Berl)       Date:  2019-10-21       Impact factor: 4.599

6.  Prostaglandin 2α Promotes Autophagy and Mitochondrial Energy Production in Fish Hepatocytes.

Authors:  Jingjing Tian; Yihui Du; Ermeng Yu; Caixia Lei; Yun Xia; Peng Jiang; Hongyan Li; Kai Zhang; Zhifei Li; Wangbao Gong; Jun Xie; Guangjun Wang
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

Review 7.  Association between liver targeted antiviral therapy in colorectal cancer and survival benefits: An appraisal.

Authors:  Qiang Wang; Chao-Ran Yu
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

8.  The inflammation - cancer connection.

Authors:  Alberto Mantovani
Journal:  FEBS J       Date:  2018-02       Impact factor: 5.542

Review 9.  The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review.

Authors:  Matthias Pinter; Rakesh K Jain; Dan G Duda
Journal:  JAMA Oncol       Date:  2021-01-01       Impact factor: 31.777

Review 10.  Cancer and hepatic steatosis.

Authors:  R Paternostro; W Sieghart; M Trauner; M Pinter
Journal:  ESMO Open       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.